Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment
The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...
Business Wire4d
Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A
Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...
Morningstar4d
Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A
With new backing from AIX Ventures, Peter Thiel, and healthcare and AI pioneers, Ataraxis AI is positioned to rapidly bring its first offering, Ataraxis Breast, to market Ataraxis AI, the leading ...
Le Lézard4d
Planful Elevates Customer Service with New Innovations to Drive Even Faster Resolutions and Greater Efficiency
Planful Inc., the pioneer of financial performance management cloud software, has made strategic investments designed to enhance the customer experience and further strengthen its award-winning ...
Le Lézard4d
YunoJuno Announces First Profitable Quarter in Q4 2024, Cementing Position as Leading Compliant Freelancer Management Platform
YunoJuno, the premier enterprise Freelance Management System, today announced its first profitable quarter in Q4 2024, marking a significant milestone in the company's growth trajectory. This ...
MusicFestNews5d
Whippersnap Music & Arts Festival Rocks Year Two in Florida
This year’s Whippersnap Music & Arts Festival, the second in Florida after years of success in the Chicago area, blew out a ...
Precision Medicine Online4d
Precision Medicine Startup Ataraxis AI Nabs $20.4M in Series Financing
Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.